Trehalose versus glycine air-polishing for peri-implant mucositis
Official title: Comparison of Trehalose and Glycine Air-Polishing Powders in the Supportive Treatment of Peri-Implant Mucositis and Their Effect on Implant Surface Integrity: A Randomized Controlled Clinical Trial
Run by University of Pavia · NCT07140146 · Data updated 2026-11-12
This trial will see if trehalose or glycine powder used with air-polishing better reduces plaque and bleeding around dental implants in adults with peri-implant mucositis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | University of Pavia Academic / other |
| Locations | 1 site (Pavia, Lombardy) |
| Status | Recruiting |
| Started | August 30, 2025 |
| Main results expected | June 1, 2026 |
| Study ends | June 10, 2026 |
| Registry record updated | February 20, 2026 |
| Trial ID | NCT07140146 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with peri-implant mucositis (bleeding on probing without radiographic bone loss), visible implant biofilm, good oral hygiene, and ability to attend all follow-up visits are ideal candidates.
✕Probably not a fit
Patients with peri-implantitis (radiographic bone loss), uncontrolled systemic conditions, recent antibiotic or anti-inflammatory use, current smokers, pregnant or breastfeeding women, or those unable to attend follow-ups are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled trial will enroll 40 adults with peri-implant mucositis who will be randomly assigned to non-surgical supportive therapy plus air-polishing with either trehalose (test) or glycine (control) powder. Clinical measures including Plaque Index, Bleeding on Probing, Probing Pocket Depth, and Bleeding Score will be recorded at baseline and at 1, 3, and 6 months to compare outcomes over time. The primary endpoint is reduction in plaque levels between groups, with secondary endpoints covering changes in gingival inflammation and probing depth. In addition, in vitro scanning electron microscopy will be used to examine implant surface effects of the powders.
Why it matters
Potential benefit: If successful, one powder could be shown to remove biofilm more effectively or more gently, improving soft-tissue health around implants and lowering progression risk to peri-implantitis.
How similar studies have gone: Glycine air-polishing has established evidence for safe and effective biofilm removal with low abrasiveness, while clinical data on trehalose for this use are limited and more novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged between 18 and 70 years * Presence of peri-implant mucositis, defined as bleeding on probing (BoP) around implants without radiographic evidence of bone loss beyond initial remodeling * Visible biofilm on implant surfaces * Ability to understand and sign informed consent * Good oral hygiene and patient compliance * Availability for all follow-up visits (1, 3, and 6 months) Exclusion Criteria: * Presence of systemic conditions that may affect healing (e.g., uncontrolled diabetes, immunosuppression) * Current smokers or former smokers who quit less than 6 months ago * Pregnant or breastfeeding women * Use of antibiotics or anti-inflammatory drugs in the 3 months prior to baseline * Presence of peri-implantitis (i.e., bleeding on probing with concomitant radiographic bone loss) * History of head and neck radiotherapy * Presence of pacemakers or cardiac stimulators * Neurological or psychological disorders affecting study compliance
Where it's running
-
Unit of Orthodontics and Pediatric Dentistry - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Pediatrics - University of Pavia
Pavia, Lombardy, Italy Recruiting
Study contacts
- Principal investigator: Andrea Scribante, Associate Professor — University of Pavia
- Study coordinator: Andrea Scribante, Associate Professor
- Email: andrea.scribante@unipv.it
- Phone: +39 0382516223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-use dual-light antibacterial therapy for peri-implant mucositis around full-arch implants
This study tests whether a home-use dual-light device added to standard care can better control gum inflammation around full-arch dental implants than standard care alone.
-
How Smoking Affects Immune Responses Around Dental Implants
This study tests how smoking changes the body's immune response around dental implants in people with healthy implants, peri-implant mucositis, or peri-implantitis.
-
AmbiJet-assisted treatment for inflamed dental implants
This study tests whether applying cold atmospheric plasma with the AmbiJet system after standard cleaning helps reduce inflammation around dental implants more quickly in adults with peri-implant mucositis or peri-implantitis.
-
AI-assisted colorimetric detection of implant gum redness
This project will test whether an AI tool can use color information from dental scans to detect redness around implant-supported gums in adults who come for implant maintenance.
-
Autogenous Palatal Graft Effects on Peri-implant Mucosa During Second-Stage Implants
This study tests whether grafts taken from different parts of the palate can improve the soft tissue around dental implants in adults who are already receiving a second-stage implant procedure.
-
Does probe material affect peri-implant probing accuracy?
This study tests whether plastic or metal periodontal probes give different probe depths around single implants when a crown is in place versus removed.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.